Permeability, zonulin production, and enteropathy in dermatitis herpetiformis.

BACKGROUND & AIMS Dermatitis herpetiformis (DH) is characterized by variable degrees of enteropathy and increased intestinal permeability. Zonulin, a regulator of tight junctions, seems to play a key role in the altered intestinal permeability that characterizes the early phase of celiac disease. Our aim was to assess both intestinal permeability and serum zonulin levels in a group of patients with DH having variable grades of enteropathy. METHODS We studied 18 DH patients diagnosed on the basis of characteristic immunoglobulin (Ig)A granular deposits in the dermal papillae of noninvolved skin. Results were compared with those of classic celiac patients, patients with linear IgA dermatosis, and healthy controls. RESULTS According to Marsh's classification, 5 patients had no evidence of enteropathy (type 0), 4 patients had type II, 2 patients had type IIIb damage, and 7 patients had a more severe lesion (type IIIc). Intestinal permeability (lactulose/mannitol ratio [lac/man]) was abnormal in all patients with DH. Patients with more severe enteropathy had significantly greater permeability ( P < .05). The serum zonulin concentration (enzyme-linked immunosorbent assay) for patients with DH was 2.1 +/- .3 ng/mg with 14 of 16 (87.5%) patients having abnormally increased values. In contrast, patients with linear IgA dermatosis had normal histology, normal intestinal permeability, and negative celiac serology. CONCLUSIONS Increased intestinal permeability and zonulin up-regulation are common and concomitant findings among patients with DH, likely involved in pathogenesis. Increased permeability can be observed even in patients with no evidence of histologic damage in biopsy specimens. Patients with linear IgA dermatosis appear to be a distinct population with no evidence of gluten sensitivity.

[1]  A. Axon,et al.  Lactulose/mannitol test: an ideal screen for celiac disease. , 1989, Gastroenterology.

[2]  G. Corazza,et al.  Coeliac disease , 2005, Journal of Clinical Pathology.

[3]  A. Fasano,et al.  Human zonulin, a potential modulator of intestinal tight junctions. , 2000, Journal of cell science.

[4]  G. Oberhuber,et al.  Gastrointestinal permeability in celiac disease. , 1997, Gastroenterology.

[5]  M N Marsh,et al.  Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). , 1992, Gastroenterology.

[6]  A. Axon,et al.  Intestinal permeability and screening tests for coeliac disease. , 1980, Gut.

[7]  A. Fasano,et al.  Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. , 2001, Gastroenterology.

[8]  E. Smecuol,et al.  Antibodies to human recombinant tissue transglutaminase may detect coeliac disease patients undiagnosed by endomysial antibodies , 2003, Alimentary pharmacology & therapeutics.

[9]  R. Batt,et al.  Abnormal permeability precedes the development of a gluten sensitive enteropathy in Irish setter dogs. , 1991, Gut.

[10]  S. Virgiliis,et al.  Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function , 2003, Gut.

[11]  E. Smecuol,et al.  Sugar tests detect celiac disease among first-degree relatives , 1999, American Journal of Gastroenterology.

[12]  H. Vázquez,et al.  Screening for asymptomatic celiac sprue in families. , 1995, Journal of clinical gastroenterology.

[13]  M. Turner,et al.  Intestinal Sugar Permeability: Relationship to Diarrhoeal Disease and Small Bowel Morphology , 1985, Journal of pediatric gastroenterology and nutrition.

[14]  W. Samowitz,et al.  Linear IgA bullous dermatosis responsive to a gluten-free diet. , 2001 .

[15]  L. Fry 9 Dermatitis herpetiformis , 1995 .

[16]  A. Price,et al.  Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis. , 1985, Gut.

[17]  D. Schuppan,et al.  Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. , 1999, The Journal of investigative dermatology.

[18]  C. Griffiths,et al.  Intestinal permeability in dermatitis herpetiformis. , 1988, The Journal of investigative dermatology.

[19]  C. Mulder,et al.  Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. , 1993, Gut.

[20]  G. Neale,et al.  51Cr-EDTA/14C-mannitol intestinal permeability test. Clinical use in screening for coeliac disease. , 1988, Scandinavian journal of gastroenterology.

[21]  A. Axon,et al.  Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease. , 1978, British medical journal.

[22]  A. Axon,et al.  Small intestinal permeability in dermatological disease. , 1985, The Quarterly journal of medicine.

[23]  A. Fasano,et al.  Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease , 2000, The Lancet.

[24]  T. Peters,et al.  A PERSISTENT DEFECT IN INTESTINAL PERMEABILITY IN COELIAC DISEASE DEMONSTRATED BY A 51Cr-LABELLED EDTA ABSORPTION TEST , 1983, The Lancet.

[25]  S. Shuster,et al.  Small-bowel changes in dermatitis herpetiformis. , 1966, Lancet.

[26]  W. W. Buchanan,et al.  LYSOSOMES IN DIVIDING CELLS. , 1965, Lancet.

[27]  V. Poggi,et al.  Immunologic and intestinal permeability tests as predictors of relapse during gluten challenge in childhood coeliac disease. , 1994, Scandinavian journal of gastroenterology.

[28]  S. Jabłońska,et al.  Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis. , 2001, Clinical immunology.